Market Movements and Corporate Concerns

This chapter delves into the implications of a controversial Skydance deal and the departure of key investor Edgar Bronfen. It also covers diverse topics such as Lilly's new drug launch, IBM's R&D closures in China, Boeing's future prospects, and political developments affecting U.S. companies.